|
67 Companies |
|
113 Products |
|
113 Products |
|
93 Mechanisms of Action |
|
9 Trials |
|
1067 News |
|
| 12345678910111213...2122» |
- | Enrollment change, Trial withdrawal: Polypill Effects on Sub Clinical Atherosclerosis (PESCA) Trial (clinicaltrials.gov) - Sep 28, 2023
P3, N=0, Withdrawn, Sponsor: Imperial College London
N=665 --> 0 | Completed --> Withdrawn
- | Phase classification: PACIFIER: Paclitaxel-coated Balloons in Femoral Indication to Defeat Restenosis (clinicaltrials.gov) - May 6, 2023
P3, N=90, Completed, Sponsor: University Hospital, Saarland
N=665 --> 0 | Completed --> Withdrawn Phase classification: P4 --> P3
- | Phase classification: Women's Isoflavone Soy Health (WISH) Trial (clinicaltrials.gov) - May 6, 2023
P2, N=350, Completed, Sponsor: University of Southern California
Phase classification: P4 --> P3 Phase classification: P2/3 --> P2
- Phase classification: PARADIGM: Popliteal Artery of Treatment With Balloon Angioplasty vs. SUPERA VERITAS Peripheral Stent System (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=0, Withdrawn, Sponsor: Abbott Medical Devices
Phase classification: P2/3 --> P2 Phase classification: P3 --> P=N/A
- | Enrollment change, Trial termination: Effects of REnal Denervation for Resistant Hypertension on Exercise Diastolic Function and Regression of Atherosclerosis and the Evaluation of NEW Methods Predicting A successfuL Renal Sympathetic Denervation (RENEWAL-EXERCISE, -REGRESS, and -PREDICT Trial From RENEWAL RDN Registry) (clinicaltrials.gov) - Apr 20, 2019
P4, N=16, Terminated, Sponsor: Yonsei University
Phase classification: P3 --> P=N/A N=52 --> 16 | Recruiting --> Terminated; The study terminated early due to the difficulty of recruiting candidates.
- | Trial completion: OLNAMS: Olive Oil and Nampt on Postprandial Inflammation and Atherosclerosis in the Setting of Metabolic Syndrome (clinicaltrials.gov) - Mar 13, 2019
P=N/A, N=40, Completed, Sponsor: National Research Council, Spain
N=52 --> 16 | Recruiting --> Terminated; The study terminated early due to the difficulty of recruiting candidates. Active, not recruiting --> Completed
- | Phase classification: Assessment of Coronary Plaque Composition (clinicaltrials.gov) - Mar 5, 2019
P1, N=39, Completed, Sponsor: Mayo Clinic
Active, not recruiting --> Completed Phase classification: P=N/A --> P1
- | Trial completion, Enrollment change: Exercise for Women With Peripheral Arterial Disease (clinicaltrials.gov) - Mar 2, 2019
P=N/A, N=33, Completed, Sponsor: University of Oklahoma
Phase classification: P=N/A --> P1 Recruiting --> Completed | N=74 --> 33
- | Phase classification: EverFlex™ Self-expanding Peripheral Stent With Entrust™ Delivery System Clinical Study (clinicaltrials.gov) - Mar 1, 2019
P=N/A, N=34, Completed, Sponsor: Medtronic Endovascular
Recruiting --> Completed | N=74 --> 33 Phase classification: P4 --> P=N/A
- | Phase classification: DURABILITY II: Safety and Effectiveness Study of EverFlex Stent to Treat Symptomatic Femoral-popliteal Atherosclerosis (clinicaltrials.gov) - Feb 18, 2019
P=N/A, N=287, Completed, Sponsor: Medtronic Endovascular
Phase classification: P4 --> P=N/A Phase classification: P2/3 --> P=N/A
- ||| emiplacel (PLX-PAD) - Pluri, Charite / University of Medicine Berlin
Trial completion, Trial completion date: Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC) (clinicaltrials.gov) - Feb 12, 2019
P2, N=180, Completed, Sponsor: Pluristem Ltd.
Phase classification: P2/3 --> P=N/A Active, not recruiting --> Completed | Trial completion date: Apr 2018 --> Feb 2019
- | pravastatin / Generic mfg., rosuvastatin / Generic mfg.
Trial completion, Trial completion date, Trial primary completion date: A Trial Comparing the Effect of Pravastatin and Rosuvastatin on Atherosclerosis Progression Measured by Carotid Intima Media Thickness in Patients With Coronary Artery Disease After Biolimus Eluting Stent (Nobori®) Implantation: CPR IMT (clinicaltrials.gov) - Jan 22, 2019
P=N/A, N=671, Completed, Sponsor: Yonsei University
Active, not recruiting --> Completed | Trial completion date: Apr 2018 --> Feb 2019 Recruiting --> Completed | Trial completion date: May 2018 --> May 2017 | Trial primary completion date: May 2018 --> May 2017
- | Trial completion: SPRINTFAST: Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study (clinicaltrials.gov) - Jan 5, 2019
P=N/A, N=595, Completed, Sponsor: University of Utah
Recruiting --> Completed | Trial completion date: May 2018 --> May 2017 | Trial primary completion date: May 2018 --> May 2017 Active, not recruiting --> Completed
- | Trial completion, Phase classification: NORSTENT: Trial of Drug Eluting Stent Versus Bare Metal Stent to Treat Coronary Artery Stenosis (clinicaltrials.gov) - Dec 24, 2018
P=N/A, N=9013, Completed, Sponsor: University of Tromso
Active, not recruiting --> Completed Active, not recruiting --> Completed | Phase classification: P4 --> PN/A
- | Trial completion: Bard® LifeStent® Vascular Stent Delivery System Study (clinicaltrials.gov) - Nov 8, 2018
P=N/A, N=76, Completed, Sponsor: C. R. Bard
Active, not recruiting --> Completed | Phase classification: P4 --> PN/A Active, not recruiting --> Completed
- | Trial completion, Trial completion date: MicroCAD: Myocardial Ischemia in Non-obstructive Coronary Artery Disease (clinicaltrials.gov) - Nov 6, 2018
P=N/A, N=132, Completed, Sponsor: University of Bergen
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Dec 2014 --> Dec 2017
- | Trial completion, Enrollment change: ASCIT: Arterial Stiffness and Calcifications in Incident Renal Transplant Recipients (clinicaltrials.gov) - Oct 17, 2018
P=N/A, N=304, Completed, Sponsor: Universitaire Ziekenhuizen Leuven
Active, not recruiting --> Completed | Trial completion date: Dec 2014 --> Dec 2017 Recruiting --> Completed | N=100 --> 304
- | Trial completion, Surgery: Assessment of Bypass Surgery and Balloon Angioplasty Effects in Peripheral Arterial Disease Using Contrast Ultrasound (clinicaltrials.gov) - Oct 12, 2018
P=N/A, N=30, Completed, Sponsor: University Hospital Freiburg
Recruiting --> Completed | N=100 --> 304 Active, not recruiting --> Completed
- | metformin / Generic mfg.
Enrollment change, Trial termination: Metformin, Muscle Energetics, and Vascular Function in Older Adults With Peripheral Artery Disease (clinicaltrials.gov) - Sep 24, 2018
P4, N=2, Terminated, Sponsor: Brigham and Women's Hospital
Active, not recruiting --> Completed N=72 --> 2 | Recruiting --> Terminated; study was not funded
- | Trial completion, Trial completion date, Trial primary completion date: The Effect of Cranberry Extract Supplementation on Cardiovascular Risk Factors in Obese, Insulin Resistant Humans (clinicaltrials.gov) - Aug 28, 2018
P=N/A, N=35, Completed, Sponsor: Pennington Biomedical Research Center
N=72 --> 2 | Recruiting --> Terminated; study was not funded Active, not recruiting --> Completed | Trial completion date: Oct 2017 --> Jul 2018 | Trial primary completion date: Oct 2016 --> Jun 2016
- | Trial completion: Treatment of Chronic Critical Limb Ischemia With G-CSF-mobilized Autologous Peripheral Blood Mononuclear Cells (clinicaltrials.gov) - Aug 17, 2018
P3, N=8, Completed, Sponsor: Mahidol University
Active, not recruiting --> Completed | Trial completion date: Oct 2017 --> Jul 2018 | Trial primary completion date: Oct 2016 --> Jun 2016 Recruiting --> Completed
- | Resolute ZES (zotarolimus-eluting stent) / Medtronic, Xience (everolimus-eluting stent) / Abbott
Phase classification, Enrollment change, Trial withdrawal: Assessment of Stent Strut Coverage and Endothelial Function After Drug-Eluting Stents (clinicaltrials.gov) - Aug 3, 2018
P=N/A, N=0, Withdrawn, Sponsor: Hyogo College of Medicine
Recruiting --> Completed Phase classification: P4 --> P=N/A | N=60 --> 0 | Recruiting --> Withdrawn
- | Trial completion, Trial primary completion date: ADCAT: Atherectomy and Drug-Coated Balloon Angioplasty in Treatment of Long Infrapopliteal Lesions (clinicaltrials.gov) - Aug 3, 2018
P=N/A, N=80, Completed, Sponsor: Herz-Zentrums Bad Krozingen
Phase classification: P4 --> P=N/A | N=60 --> 0 | Recruiting --> Withdrawn Recruiting --> Completed | Trial primary completion date: Nov 2017 --> Mar 2018
- | Xience (everolimus-eluting stent) / Abbott
Trial completion: PROMUS Element Plus US Post-Approval Study (clinicaltrials.gov) - Jul 27, 2018
P4, N=2681, Completed, Sponsor: Boston Scientific Corporation
Recruiting --> Completed | Trial primary completion date: Nov 2017 --> Mar 2018 Active, not recruiting --> Completed
- | Trial completion: Examining the Link Between Heart Disease and HIV Infection in Women (clinicaltrials.gov) - Jul 13, 2018
P=N/A, N=1011, Completed, Sponsor: Albert Einstein College of Medicine, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: AcoArt Ⅰ / SFA China (clinicaltrials.gov) - Jul 12, 2018
P=N/A, N=200, Completed, Sponsor: Acotec Scientific Co., Ltd
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Trial completion date: BIOFLEX-I: Investigational Device Exemption Study to Determine the Safety and Efficacy of the Astron and Pulsar Stents (clinicaltrials.gov) - Jul 10, 2018
P2, N=463, Completed, Sponsor: Biotronik, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Jun 2018 --> Sep 2017
- ||| Trial completion: Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System (clinicaltrials.gov) - Jun 29, 2018
P=N/A, N=257, Completed, Sponsor: Cordis Corporation
Active, not recruiting --> Completed | Trial completion date: Jun 2018 --> Sep 2017 Active, not recruiting --> Completed
- | Trial completion: A Proposed Study of Atherosclerotic Plaques in Leg Arteries (clinicaltrials.gov) - Jun 29, 2018
P=N/A, N=10, Completed, Sponsor: Southwest Regional Wound Care Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Phase classification, Enrollment change: Longitudinal Study in Perimenopausal Women With Risk Factors for Atherosclerosis (clinicaltrials.gov) - Apr 6, 2018
P, N=177, Completed, Sponsor: Ohio State University
Active, not recruiting --> Completed Active, not recruiting --> Completed | Phase classification: PN/A --> P | N=100 --> 177
- | Phase classification, Enrollment change: Age-Related Changes in Body Composition (clinicaltrials.gov) - Apr 6, 2018
P, N=24, Terminated, Sponsor: National Institute on Aging (NIA)
Active, not recruiting --> Completed | Phase classification: PN/A --> P | N=100 --> 177 Phase classification: P=N/A --> P | N=350 --> 24
- | Trial termination: Outcomes of Femoro-popliteal Disease After Stent Deployment Under Intravascular Ultrasound Guidance (clinicaltrials.gov) - Mar 21, 2018
P=N/A, N=8, Terminated, Sponsor: Texas Tech University Health Sciences Center
Phase classification: P=N/A --> P | N=350 --> 24 Active, not recruiting --> Terminated; PI left institution--only 8 subjects were enrolled.
- | Enrollment change, Trial withdrawal: SENS-FP: Efficacy Between Different Two Self-Expanding Nitinol Stents For The Atherosclerotic Femoro-Popliteal Arterial Disease (clinicaltrials.gov) - Mar 15, 2018
P=N/A, N=0, Withdrawn, Sponsor: Korea University Guro Hospital
Active, not recruiting --> Terminated; PI left institution--only 8 subjects were enrolled. N=346 --> 0 | Recruiting --> Withdrawn
- | Trial completion: Improving Intermediate Risk Management. MARK Study (clinicaltrials.gov) - Mar 9, 2018
P=N/A, N=2495, Completed, Sponsor: Jordi Gol i Gurina Foundation
N=346 --> 0 | Recruiting --> Withdrawn Active, not recruiting --> Completed
- |||| Trial completion, Trial completion date: DANCE: Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease (clinicaltrials.gov) - Mar 8, 2018
P4, N=285, Completed, Sponsor: Mercator MedSystems, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Jan 2018
- | Phase classification: VISIBILITY™ Iliac Study (clinicaltrials.gov) - Mar 7, 2018
P=N/A, N=75, Completed, Sponsor: Medtronic Endovascular
Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Jan 2018 Phase classification: P2/3 --> P=N/A
- | Phase classification: DURABILITY™ Iliac Study (clinicaltrials.gov) - Mar 7, 2018
P=N/A, N=75, Completed, Sponsor: Medtronic Endovascular
Phase classification: P2/3 --> P=N/A Phase classification: P2/3 --> P=N/A
- Enrollment change, Trial termination, Trial primary completion date: ROVER: Registry of the Magellan Robotic System (clinicaltrials.gov) - Mar 1, 2018
P=N/A, N=348, Terminated, Sponsor: Hansen Medical
Phase classification: P2/3 --> P=N/A N=1000 --> 348 | Recruiting --> Terminated | Trial primary completion date: Nov 2018 --> Aug 2016
- | Trial completion: Non-invasive Cardiac Screening in High Risk Patients -The GROUND Study (clinicaltrials.gov) - Feb 15, 2018
P3, N=1200, Completed, Sponsor: Clinical Research Office Imaging Division
N=1000 --> 348 | Recruiting --> Terminated | Trial primary completion date: Nov 2018 --> Aug 2016 Recruiting --> Completed
- | Enrollment change, Trial primary completion date: SUPER Study; SUPERvised Exercise or Angioplasty for Intermittent Claudication Due to an Iliac Artery Obstruction. (clinicaltrials.gov) - Feb 13, 2018
P=N/A, N=240, Terminated, Sponsor: M.J.W. Koelemaij
Recruiting --> Completed N=400 --> 240 | Trial primary completion date: Nov 2013 --> May 2016
- | Enrollment open, Enrollment change, Trial primary completion date: Exercise for Women With Peripheral Arterial Disease (clinicaltrials.gov) - Feb 1, 2018
P=N/A, N=74, Recruiting, Sponsor: University of Oklahoma
N=400 --> 240 | Trial primary completion date: Nov 2013 --> May 2016 Completed --> Recruiting | N=33 --> 74 | Trial primary completion date: Mar 2016 --> Jul 2019
- | Trial termination: Genetic and Inflammatory Markers in Cardiovascular Disease (GEM) Registry (clinicaltrials.gov) - Jan 31, 2018
P=N/A, N=21, Terminated, Sponsor: University of California, Davis
Completed --> Recruiting | N=33 --> 74 | Trial primary completion date: Mar 2016 --> Jul 2019 Active, not recruiting --> Terminated
- Trial completion: Safety Trial Of CTX Cells In Patients With Lower Limb Ischaemia (clinicaltrials.gov) - Jan 31, 2018
P1, N=5, Completed, Sponsor: ReNeuron Limited
Active, not recruiting --> Terminated Active, not recruiting --> Completed
- | dexamethasone / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Dexamethasone Infusion to the Adventitia to Enhance Clinical Efficacy After Femoropopliteal Revascularization (clinicaltrials.gov) - Jan 8, 2018
P=N/A, N=22, Completed, Sponsor: University of California, San Francisco
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=30 --> 22 | Trial primary completion date: Jun 2016 --> Dec 2015
- | Trial completion: DAG: Screening for Arteriopathy in General Medicine: a Preliminary Feasibility Study (clinicaltrials.gov) - Jan 3, 2018
P=N/A, N=300, Completed, Sponsor: Centre Hospitalier Universitaire de N?mes
Active, not recruiting --> Completed | N=30 --> 22 | Trial primary completion date: Jun 2016 --> Dec 2015 Recruiting --> Completed
- | Trial completion, Surgery: Platelet Activity in Vascular Surgery for Thrombosis and Bleeding (clinicaltrials.gov) - Dec 14, 2017
P=N/A, N=200, Completed, Sponsor: New York University School of Medicine
Recruiting --> Completed Recruiting --> Completed
- ||| Trial completion, Trial primary completion date: iCARE: Individualized Comprehensive Atherosclerosis Risk-reduction Evaluation Program (clinicaltrials.gov) - Nov 20, 2017
P=N/A, N=170, Completed, Sponsor: Piedmont Healthcare
Recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Jul 2017 --> Dec 2016
- | Trial completion, Phase classification, Enrollment change, Trial primary completion date: Decide CTA: Detection of Subclinical Atherosclerosis in Asymptomatic Individuals (clinicaltrials.gov) - Nov 20, 2017
P=N/A, N=73, Completed, Sponsor: Piedmont Healthcare
Active, not recruiting --> Completed | Trial primary completion date: Jul 2017 --> Dec 2016 Recruiting --> Completed | Phase classification: P1 --> PN/A | N=300 --> 73 | Trial primary completion date: Jul 2014 --> Jul 2013
- | Trial completion: NIA-Plaque: High-Density Lipoprotein (HDL) Cholesterol Increased Plaque Stabilization in the Elderly (clinicaltrials.gov) - Nov 6, 2017
P3, N=145, Completed, Sponsor: Johns Hopkins University
Recruiting --> Completed | Phase classification: P1 --> PN/A | N=300 --> 73 | Trial primary completion date: Jul 2014 --> Jul 2013 Active, not recruiting --> Completed
- | Trial completion: Inflammation Genomics and Atherosclerosis - Ancillary to CARDIA (clinicaltrials.gov) - Nov 6, 2017
P=N/A, N=3600, Completed, Sponsor: University of Washington
Active, not recruiting --> Completed No longer recruiting --> Completed